Abbott Laboratories (ABT) is expected to report earnings on Wednesday, October 21, 2026, before the open. Estimated release time 07:35 ET. Consensus EPS estimate is $1.43.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-16 | FY2026 Q2 | $1.28 | $1.31 | +2.3% | $12.59B |
| 2026-04-29 | FY2026 Q1 | $1.14 | $1.15 | +0.9% | $11.16B |
| 2026-02-20 | FY2025 Q4 | $1.50 | $1.50 | +0.0% | $11.46B |
| 2025-10-29 | FY2025 Q3 | $1.30 | $1.30 | +0.0% | $11.37B |
| 2025-07-30 | FY2025 Q2 | $1.26 | $1.26 | +0.0% | $11.14B |
| 2025-04-30 | FY2025 Q1 | $1.07 | $1.09 | +1.9% | $10.36B |
| 2025-02-21 | FY2024 Q4 | $1.34 | $1.34 | +0.0% | $10.97B |
| 2024-10-31 | FY2024 Q3 | $1.20 | $1.21 | +0.8% | $10.63B |
ABT has beaten consensus EPS in 8 of its last 8 reported quarters.
See ABT on the live calendar →